Levi & Korsinsky notifies investors that it has commenced an investigation into Valneva SE (NASDAQ: VALN) concerning potential violations of the federal securities laws.
On August 25, 2025, before the market opened, Valneva announced that the FDA suspended the license for its chikungunya vaccine IXCHIQ due to new reports of serious adverse events consistent with chikungunya-like illness. The suspension is effective immediately and Valneva is required to stop the shipping and selling of its IXCHIQ vaccine in the U.S. Following this news, VALN’s stock price fell over 22% to open at $9.12 per share.
If you suffered a loss on your Valneva SE securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





